SVB Leerink, an investment bank specializing in healthcare and life sciences, added Thad Davis to the firm as a senior managing director.
Davis will be part of the team leading SVB Leerink’s leveraged finance franchise while contributing to the firm’s strategic, M&A and equity franchises. He joined recent hires Barry Blake, global co-head of investment banking, and Robert Minear, senior managing director for financial sponsors.
“SVB Leerink is excited to welcome Thad. His experience encompasses all healthcare sub-sectors including pharmaceuticals, life sciences, services, devices, technology and managed care,” Blake said. “Thad will provide immediate value to the team and will bring many significant client relationships that extend beyond his leveraged finance focus.”
Davis will be based in New York City and report to Blake. Davis joined the firm from HSBC, where he served as head of U.S. healthcare investment banking and was responsible for healthcare coverage, including origination, relationship oversight, team leadership and transaction execution. Prior to HSBC, Davis was a managing director within the respective global healthcare teams of Jefferies and UBS.
“SVB Leerink is extremely well-positioned for its leveraged finance expansion,” Davis said. “Joining alongside respected industry leaders like Barry and Rob only emphasizes the firm’s capabilities and upward trajectory.”
